Sectoral Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History

Sectoral Asset Management’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Hold	23,500	–	–	0.18%	75
2026 Q1	$333K	Buy	23,500 +1,020	+5%	+$11.6K	0.28%	67
2025 Q4	$184K	Sell	22,480 -306,175	-93%	-$3.52M	0.15%	73
2025 Q3	$3.94M	Buy	328,655 +97,170	+42%	+$1.02M	2.43%	10
2025 Q2	$2.35M	Buy	231,485 +211,485	+1,057%	+$1.42M	1.55%	11
2025 Q1	$112K	Buy	+20,000	New	+$175K	0.09%	78

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sectoral Asset Management's ORIC Position: Q2 2026 in Review

Sectoral Asset Management held its Oric Pharmaceuticals (ORIC) position steady in Q2 2026 at 23,500 shares worth $255K. The position accounts for 0.18% of the portfolio, ranked #75.

Sectoral Asset Management first reported a position in ORIC in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.94M in Q3 2025. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Sectoral Asset Management held 23,500 shares of Oric Pharmaceuticals worth $255K as of Q2 2026.
Sectoral Asset Management left its Oric Pharmaceuticals share count unchanged in Q2 2026.
Oric Pharmaceuticals made up 0.18% of Sectoral Asset Management's portfolio in Q2 2026, its #75 holding.
Sectoral Asset Management first reported a position in Oric Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Sectoral Asset Management's Oric Pharmaceuticals position peaked at $3.94M in Q3 2025.
181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.